Emergence of serotype IV group B streptococcus adult invasive disease in Manitoba and saskatchewan, Canada, is driven by clonal sequence type 459 strains

Journal of Clinical Microbiology

Volumn 53, Issue 9, 2015, Pages 2919-2926

  Teatero, Sarah ^a   Athey, Taryn B T ^a   Van Caeseele, Paul ^b   Horsman, Greg ^c   Alexander, David C ^c   Melano, Roberto G ^a,d,e   Li, Aimin ^a   Flores, Anthony R ^f   Shelburne, Samuel A ^g   McGeer, Allison ^d,e   Demczuk, Walter ^h   Martin, Irene ^h   Fittipaldi, Nahuel ^a,e  

^a PUBLIC HEALTH ONTARIO   (Canada)

^b CADHAM PROVINCIAL LABORATORY   (Canada)

^c Saskatchewan Disease Control Laboratory   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CANADA; ERMTR GENE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC CODE; GROUP B STREPTOCOCCAL INFECTION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POPULATION STRUCTURE; PRIORITY JOURNAL; SEROTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; STREPTOCOCCUS AGALACTIAE; TETM GENE; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL GENOME; CLASSIFICATION; CLUSTER ANALYSIS; DRUG EFFECTS; FEMALE; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MALE; MANITOBA; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MOLECULAR GENETICS; PHYLOGENY; SASKATCHEWAN; STREPTOCOCCAL INFECTIONS; VERY ELDERLY; YOUNG ADULT;

STREPTOCOCCUS SP. 'GROUP B';

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOME, BACTERIAL; GENOTYPE; HUMANS; MALE; MANITOBA; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; SASKATCHEWAN; SEROGROUP; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; YOUNG ADULT;

EID: 84940055944     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01128-15     Document Type: Article

References (47)

1. Baker CJ. 1997. Group B streptococcal infections. Clin Perinatol 24: 59 -70.
2. Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, Harrison LH, Lynfield R, Mohle-Boetani J, Zansky S, Albanese BA, Stefonek K, Zell ER, Jackson D, Thompson T, Schrag SJ. 2009. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 49:85-92. http://dx.doi.org/10.1086/599369.
3. Farley MM. 2001. Group B streptococcal disease in nonpregnant adults. Clin Infect Dis 33:556-561. http://dx.doi.org/10.1086/322696.
4. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, Stefonek KR, Albanese BA, Zell ER, Schuchat A, Schrag SJ, Active Bacterial Core surveillance/ Emerging Infections Program Network. 2008. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299: 2056-2065. http://dx.doi.org/10.1001/jama.299.17.2056.
5. Huang PY, Lee MH, Yang CC, Leu HS. 2006. Group B streptococcal bacteremia in non-pregnant adults. J Microbiol Immunol Infect 39: 237-241.
6. Lambertsen L, Ekelund K, Skovsted IC, Liboriussen A, Slotved HC. 2010. Characterisation of invasive group B Streptococci from adults in Denmark 1999 to 2004. Eur J Clin Microbiol Infect Dis 29:1071-1077. http://dx.doi.org/10.1007/s10096-010-0941-z.
7. Ferrieri P, Flores AE. 1997. Surface protein expression in group B streptococcal invasive isolates. Adv Exp Med Biol 418:635-637. http://dx.doi/org/10.1007/978-1-4899-1825-3-148.
8. Cieslewicz MJ, Chaffin D, Glusman G, Kasper D, Madan A, Rodrigues S, Fahey J, Wessels MR, Rubens CE. 2005. Structural and genetic diversity of group B Streptococcus capsular polysaccharides. Infect Immun 73: 3096-3103. http://dx.doi.org/10.1128/IAI.73.5.3096-3103.2005.
9. Slotved HC, Kong F, Lambertsen L, Sauer S, Gilbert GL. 2007. Serotype IX, a proposed new Streptococcus agalactiae serotype. J Clin Microbiol 45:2929-2936. http://dx.doi.org/10.1128/JCM.00117-07.
10. Harrison LH, Dwyer DM, Johnson JA. 1995. Emergence of serotype V group B streptococcal infection among infants and adults. J Infect Dis 171:513. http://dx.doi.org/10.1093/infdis/171.2.513.
11. Tyrrell GJ, Senzilet LD, Spika JS, Kertesz DA, Alagaratnam M, Lovgren M, Talbot JA. 2000. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study-1996. Sentinel Health Unit Surveillance System site coordinators. J Infect Dis 182:168-173.
12. Lamagni TL, Keshishian C, Efstratiou A, Guy R, Henderson KL, Broughton K, Sheridan E. 2013. Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991-2010. Clin Infect Dis 57:682-688. http://dx.doi.org/10.1093/cid/cit337.
13. Domelier AS, van der Mee-Marquet N, Arnault L, Mereghetti L, Lanotte P, Rosenau A, Lartigue MF, Quentin R. 2008. Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains. J Antimicrob Chemother 62:1227-1233. http://dx.doi.org/10/1093/jac/dkn388.
14. Bergseng H, Afset JE, Radtke A, Loeseth K, Lyng RV, Rygg M, Bergh K. 2009. Molecular and phenotypic characterization of invasive group B Streptococcus strains from infants in Norway 2006-2007. Clin Microbiol Infect 15:1182-1185. http://dx.doi.org/10.1111/j.1469-0691.2009.02789.x.
15. Salloum M, van der Mee-Marquet N, Valentin-Domelier AS, Quentin R. 2011. Diversity of prophage DNA regions of Streptococcus agalactiae clonal lineages from adults and neonates with invasive infectious disease. PLoS One 6:e20256. http://dx.doi.org/10.1371/journal.pone.0020256.
16. Zaleznik DF, Rench MA, Hillier S, Krohn MA, Platt R, Lee ML, Flores AE, Ferrieri P, Baker CJ. 2000. Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis 30:276-281. http://dx.doi.org/10.1086/313665.
17. Diedrick MJ, Flores AE, Hillier SL, Creti R, Ferrieri P. 2010. Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States. J Clin Microbiol 48:3100-3104. http://dx/doi.org/10.1128/JCM.00277-10.
18. Ferrieri P, Lynfield R, Creti R, Flores AE. 2013. Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000-2010. Emerg Infect Dis 19:551-558.
19. Teatero S, McGeer A, Low DE, Li A, Demczuk W, Martin I, Fittipaldi N. 2014. Characterization of invasive group B Streptococcus from the greater Toronto area, Canada. J Clin Microbiol 52:1441-1447.
20. Teatero S, McGeer A, Li A, Gomes J, Seah C, Demczuk W, Martin I, Wasserscheid J, Dewar K, Melano RG, Fittipaldi N. 2015. Population structure and antimicrobial resistance of invasive serotype IV group B Streptococcus, Toronto, Ontario, Canada. Emerg Infect Dis 21:585-591. http://dx.doi.org/10.3201/eid2014.140759.
21. Baker CJ, Clark DJ, Barrett FF. 1973. Selective broth medium for isolation of group B Streptococci. Appl Microbiol 26:884-885.
22. Heelan JS, Struminsky J, Lauro P, Sung CJ. 2005. Evaluation of a new selective enrichment broth for detection of group B Streptococci in pregnant women. J Clin Microbiol 43:896-897. http://dx.doi.org/10.1128/JCM.43.2.896-897.2005.
23. Slotved HC, Elliott J, Thompson T, Konradsen HB. 2003. Latex assay for serotyping of group B Streptococcus isolates. J Clin Microbiol 41:4445-4447. http://dx.doi.org/10.1128/JCM.41.9.4445-4447.2003.
24. Inouye M, Dashnow H, Raven LA, Schultz MB, Pope BJ, Tomita T, Zobel J, Holt KE. 2014. SRST2: Rapid genomic surveillance for public health and hospital microbiology labs. Genome medicine 6:90. http://dx/doi.org/10.1186/s13073-014-0090-6.
25. Jones N, Bohnsack JF, Takahashi S, Oliver KA, Chan MS, Kunst F, Glaser P, Rusniok C, Crook DW, Harding RM, Bisharat N, Spratt BG. 2003. Multilocus sequence typing system for group B Streptococcus. J Clin Microbiol 41:2530-2536. http://dx.doi.org/10.1128/JCM.41.6.2530-2536/2003.
26. Huson DH, Bryant D. 2006. Application of phylogenetic networks in evolutionary studies. Mol Biol Evol 23:254-267.
27. Flores AR, Galloway-Pena J, Sahasrabhojane P, Saldana M, Yao H, Su X, Ajami NJ, Holder ME, Petrosino JF, Thompson E, Margarit YRI, Rosini R, Grandi G, Horstmann N, Teatero S, McGeer A, Fittipaldi N, Rappuoli R, Baker CJ, Shelburne SA. 2015. Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes. Proc Natl Acad Sci U S A 112:6431-6436. http://dx/doi.org/10.1073/pnas.1504725112.
28. Nusbaum C, Ohsumi TK, Gomez J, Aquadro J, Victor TC, Warren RM, Hung DT, Birren BW, Lander ES, Jaffe DB. 2009. Sensitive, specific polymorphism discovery in bacteria using massively parallel sequencing. Nat Methods 6:67-69. http://dx.doi.org/10.1038/nmeth.1286.
29. Long SW, Beres SB, Olsen RJ, Musser JM. 2014. Absence of patient-topatient intrahospital transmission of Staphylococcus aureus as determined by whole-genome sequencing. MBio 5:e01692-14.
30. Shea PR, Beres SB, Flores AR, Ewbank AL, Gonzalez-Lugo JH, Martagon-Rosado AJ, Martinez-Gutierrez JC, Rehman HA, Serrano-Gonzalez M, Fittipaldi N, Ayers SD, Webb P, Willey BM, Low DE, Musser JM. 2011. Distinct signatures of diversifying selection revealed by genome analysis of respiratory tract and invasive bacterial populations. Proc Natl Acad SciUSA 108:5039-5044. http://dx.doi.org/10.1073/pnas.1016282108.
31. Da Cunha V, Davies MR, Douarre PE, Rosinski-Chupin I, Margarit I, Spinali S, Perkins T, Lechat P, Dmytruk N, Sauvage E, Ma L, Romi B, Tichit M, Lopez-Sanchez MJ, Descorps-Declere S, Souche E, Buchrieser C, Trieu-Cuot P, Moszer I, Clermont D, Maione D, Bouchier C, McMillan DJ, Parkhill J, Telford JL, Dougan G, Walker MJ, DEVANI Consortium, Holden MT, Poyart C, Glaser P. 2014. Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline. Nat Commun 5:4544.
32. Marttinen P, Hanage WP, Croucher NJ, Connor TR, Harris SR, Bentley SD, Corander J. 2012. Detection of recombination events in bacterial genomes from large population samples. Nucleic Acids Res 40:e6. http://dx.doi.org/10.1093/nar/gkr928.
33. Alikhan NF, Petty NK, Ben Zakour NL, Beatson SA. 2011. BLAST ring image generator (BRIG): simple prokaryote genome comparisons. BMC Genomics 12:402. http://dx.doi.org/10.1186/1471-2164-12-402.
34. Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing; 23rd informational supplement. CLSI M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.
35. Sadowy E, Matynia B, Hryniewicz W. 2010. Population structure, virulence factors and resistance determinants of invasive, non-invasive and colonizing Streptococcus agalactiae in Poland. J Antimicrob Chemother 65:1907-1914. http://dx.doi.org/10.1093/jac/dkq230.
36. Brenciani A, Tiberi E, Bacciaglia A, Petrelli D, Varaldo PE, Giovanetti E. 2011. Two distinct genetic elements are responsible for erm(TR)-mediated erythromycin resistance in tetracycline-susceptible and tetracycline-resistant strains of Streptococcus pyogenes. Antimicrob Agents Chemother 55:2106-2112. http://dx.doi.org/10.1128/AAC.01378-10.
37. Tazi A, Morand PC, Reglier-Poupet H, Dmytruk N, Billoet A, Antona D, Trieu-Cuot P, Poyart C. 2011. Invasive group B streptococcal infections in adults, France (2007-2010). Clin Microbiol Infect 17:1587-1589. http://dx.doi.org/10.1111/j.1469-0691.2011.03628.x.
38. Jannati E, Roshani M, Arzanlou M, Habibzadeh S, Rahimi G, Shapuri R. 2012. Capsular serotype and antibiotic resistance of group B Streptococci isolated from pregnant women in Ardabil, Iran. Iran J Microbiol 4:130-135.
39. Kiely RA, Cotter L, Mollaghan AM, Cryan B, Coffey A, Lucey B. 2011. Emergence of group B Streptococcus serotype IV in women of childbearing age in Ireland. Epidemiol Infect 139:236-238. http://dx.doi.org/10.1017/S0950268810001275.
40. Palmeiro JK, Dalla-Costa LM, Fracalanzza SE, Botelho AC, Da Silva Nogueira K, Scheffer MC, de Almeida Torres RS, de Carvalho NS, Cogo LL, Madeira HM. 2010. Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil. J Clin Microbiol 48: 4397-4403. http://dx.doi.org/10.1128/JCM.00419-10.
41. Schrag SJ, Verani JR. 2013. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine 31(Suppl):D20-D26. http://dx.doi.org/10.1016/j.vaccine/2012.11.056.
42. Tettelin H, Masignani V, Cieslewicz MJ, Donati C, Medini D, Ward NL, Angiuoli SV, Crabtree J, Jones AL, Durkin AS, Deboy RT, Davidsen TM, Mora M, Scarselli M, Margarit y Ros I, Peterson JD, Hauser CR, Sundaram JP, Nelson WC, Madupu R, Brinkac LM, Dodson RJ, Rosovitz MJ, Sullivan SA, Daugherty SC, Haft DH, Selengut J, Gwinn ML, Zhou L, Zafar N, Khouri H, Radune D, Dimitrov G, Watkins K, O'Connor KJ, Smith S, Utterback TR, White O, Rubens CE, Grandi G, Madoff LC, Kasper DL, Telford JL, Wessels MR, Rappuoli R, Fraser CM. 2005. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome." Proc Natl Acad Sci U S A 102:13950-13955.
43. Brochet M, Rusniok C, Couve E, Dramsi S, Poyart C, Trieu-Cuot P, Kunst F, Glaser P. 2008. Shaping a bacterial genome by large chromosomal replacements, the evolutionary history of Streptococcus agalactiae. Proc Natl Acad Sci U S A 105:15961-15966. http://dx.doi.org/10.1073/pnas.0803654105.
44. Musser JM, Mattingly SJ, Quentin R, Goudeau A, Selander RK. 1989. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci U S A 86:4731-4735. http://dx.doi.org/10.1073/pnas.86.12.4731.
45. Luan SL, Granlund M, Sellin M, Lagergard T, Spratt BG, Norgren M. 2005. Multilocus sequence typing of Swedish invasive group B Streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J Clin Microbiol 43:3727-3733. http://dx.doi.org/10.1128/JCM/43.8.3727-3733.2005.
46. Glass-Kaastra SK, Finley R, Hutchinson J, Patrick DM, Weiss K, Conly J. 2014. Provincial and temporal variation in macrolide and lincosamide antimicrobial use by outpatients in Canada, 1995 to 2010. Can J Infect Dis Med Microbiol 25:103-106.
47. Jolley KA, Maiden MC. 2010. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11:595. http://dx.doi.org/10.1186/1471-2105-11-595.